多巴胺基系统中的遗传多态度与尼古丁依赖的关联:叙述性审查
Jingjing Yang1,2,3,4, Hongjuan Wang1,2,3,4, Huan Chen1,2,3,4
1China National Tobacco Quality Supervision & Test Center, Zhengzhou, 450001, China.
Heliyon
|July 18, 2024
概括
多巴胺通路中的遗传变异会影响对尼古丁成的易感性. 了解这些遗传因素是开发个性化戒烟治疗的关键.
科学领域:
- 神经科学是一个神经科学.
- 遗传学 遗传学 是一个
- 药理学 药理学是指药理学的学科.
背景情况:
- 尼古丁成是一个主要的公共卫生问题,由尼古丁对大脑多巴胺奖励系统的作用驱动.
- 多巴胺在尼古丁的奖励效果中发挥着关键作用,加强了烟草的使用并导致了依赖.
研究的目的:
- 审查当前关于多巴胺相关基因中的遗传变异 (多态) 如何影响吸烟行为和尼古丁依赖的研究.
- 为了解尼古丁依赖的遗传机制以及制定个性化戒烟策略提供基础.
主要方法:
- 关于研究多态基因与多巴胺合成,储存,释放,降解和再吸收相关的研究的文献综述.
- 分析了将这些多形态与吸烟行为和尼古丁依赖关系的研究.
主要成果:
- 关键多巴胺路径基因 (例如,氨酸氧化酶,多巴胺转运体,多巴胺受体) 的遗传多态性与对尼古丁成的不同易感性有关.
- 这些遗传变异可以影响个体的吸烟行为,尼古丁依赖程度,并可能影响他们对戒烟治疗的反应.
结论:
- 多巴胺基基因变异是尼古丁依赖的发展和维持的重要贡献者.
- 阐明这些遗传基础对于推进个人化医学的戒烟和成治疗方法至关重要.
相关概念视频
Human Genetics
556
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
The complex relationship between genetics and psychology is observable through common biological components such...
556
Drugs Acting on Autonomic Ganglia: Stimulants
1.3K
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
1.3K
Single Nucleotide Polymorphisms-SNPs
15.0K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
15.0K
Drugs Affecting Neurotransmitter Synthesis
1.3K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.3K
Drug Abuse and Addiction: Pharmacological Phenomena
459
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
459
Drugs Affecting Neurotransmitter Release or Uptake
1.0K
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.0K


